Thymoglobulin
Showing 26 - 50 of 428
Sickle Cell Disease Trial in Chicago (drug, radiation, procedure)
Recruiting
- Sickle Cell Disease
- ATG
- +6 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
Oct 21, 2021
Epidermolysis Bullosa Trial in Minneapolis (drug, radiation, procedure, biological)
Recruiting
- Epidermolysis Bullosa
- Thymoglobulin
- +8 more
-
Minneapolis, MinnesotaUniversity of Minnesota Masonic Cancer Center and Medical Center
Jan 20, 2022
Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit
Recruiting
- Sickle Cell Disease
- +4 more
- Cyclophosphamide
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 6, 2022
Hematologic Malignancy, Bone Marrow Transplant Trial in New York (Tocilizumab, Fludarabine, Melphalan)
Recruiting
- Hematologic Malignancy
- Bone Marrow Transplant
- Tocilizumab
- +4 more
-
New York, New YorkWeill Cornell Medical College
Oct 27, 2021
Diabetes, Type 1, Hypoglycemia, Autoimmune Diseases Trial in Miami (Anti-Thymocyte Globulin (ATG), Interleukin 2, Exenatide)
Not yet recruiting
- Diabetes Mellitus, Type 1
- +3 more
- Anti-Thymocyte Globulin (ATG)
- +7 more
-
Miami, FloridaDiabetes Research Institute, University of Miami Miller School o
Feb 23, 2022
Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)
Recruiting
- Crohn's Disease
- autologous CD34-selected peripheral blood stem cells transplant
- +8 more
-
Pittsburgh, Pennsylvania
- +1 more
Feb 9, 2022
Renal Failure Trial in Columbus (Everolimus, Sirolimus)
Completed
- Renal Failure
-
Columbus, OhioThe Ohio State University Wexner Medical Center
Nov 2, 2021
Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia Trial in Columbus (Romidepsin, Busulfan,
Recruiting
- Cutaneous T-cell Lymphoma
- +4 more
- Romidepsin
- +4 more
-
Columbus, OhioThe Ohio State University Cancer Center
Apr 18, 2022
Aplastic Anemia Trial run by the NHLBI (Campath-1H, r-ATG, CsA)
Completed
- Aplastic Anemia
- Campath-1H
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 2, 2021
Kidney Transplantation, Renal Transplant Recipients Trial in Atlanta (Lulizumab, Tacrolimus, Thymoglobulin®)
Not yet recruiting
- Kidney Transplantation
- Renal Transplant Recipients
- Lulizumab
- +5 more
-
Atlanta, GeorgiaEmory University Hospital
Sep 22, 2021
Hematological Malignancies, Myelodysplastic Syndrome, Leukemia Trial in Houston (Mycophenolate Mofetil (MMF), Thymoglobulin,
Terminated
- Hematological Malignancies
- +3 more
- Mycophenolate Mofetil (MMF)
- +3 more
-
Houston, TexasUT MD Anderson Cancer Center
Sep 1, 2020
Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)
Completed
- Severe Aplastic Anemia
- Bone Marrow Failure Syndromes
- Bone marrow transplant
- +7 more
-
Baltimore, Maryland
- +1 more
Feb 10, 2022
Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease Trial in Pittsburgh (Cyclophosphamide, Mesna,
Recruiting
- Systemic Sclerosis
- +3 more
- Cyclophosphamide
- +8 more
-
Pittsburgh, Pennsylvania
- +2 more
Dec 17, 2021
Lung Transplant Rejection, Antibody-mediated Rejection Trial in Saint Louis, Houston (Belatacept, Tacrolimus, ATG)
Active, not recruiting
- Lung Transplant Rejection
- Antibody-mediated Rejection
- Belatacept
- +5 more
-
Saint Louis, Missouri
- +1 more
Nov 2, 2021
Severe Aplastic Anemia Trial in Shanghai (Thymoglobulin, Cord blood, Cyclosporine Oral Product)
Recruiting
- Severe Aplastic Anemia
- Thymoglobulin
- +2 more
-
Shanghai, Shanghai, ChinaShanghai general hospital, Shanghai Jiaotong university school o
Oct 10, 2021
Severe Combined Immunodeficiency Trial in Memphis (drug, device, other)
Recruiting
- Severe Combined Immunodeficiency
- Anti-thymocyte globulin (rabbit)
- +5 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 6, 2021
MDS, Leukemia, Myeloid, Acute, Leukemia, Relapsed Adult Acute Myeloid Trial in New York (CPX-351, Fludarabine, Melphalan)
Active, not recruiting
- Myelodysplastic Syndromes
- +3 more
- CPX-351
- +4 more
-
New York, New YorkWeill Cornell Medical College
Jan 26, 2022
Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,
Completed
- Disorder Related to Bone Marrow Transplantation
- +2 more
- Fludarabine
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 18, 2021
Kidney Transplantation Trial in Argentina, United States (Thymoglobulin, Belatacept, mycophenolate mofetil(MMF))
Completed
- Kidney Transplantation
- Thymoglobulin
- +5 more
-
San Diego, California
- +19 more
May 28, 2021
Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,
Recruiting
- Autoimmune Disease
- +18 more
- Anti-Thymocyte Globulin
- +9 more
-
Denver, Colorado
- +2 more
Feb 1, 2023
Kidney Transplantation Trial in Prague (Privigen, Thymoglobulin, Plasma Exchange)
Recruiting
- Kidney Transplantation
- Privigen
- +2 more
-
Prague, CzechiaInstitute for Clinical and Experimental Medicine
Apr 3, 2021
DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly Trial in Durham (biological, other, procedure,
Completed
- DiGeorge Anomaly
- +4 more
- Cultured Thymus Tissue for Implantation (CTTI)
- +8 more
-
Durham, North CarolinaDuke University Medical Center
Mar 23, 2022